These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35502988)

  • 21. Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period: a contemporary series.
    O'Connor DJ; Scher LA; Gargiulo NJ; Jang J; Suggs WD; Lipsitz EC
    Ann Vasc Surg; 2011 Jan; 25(1):9-14. PubMed ID: 20800436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
    Bikdeli B; Caraballo C; Trujillo-Santos J; Galanaud JP; di Micco P; Rosa V; Cusidó GV; Schellong S; Mellado M; Del Valle Morales M; Gavín-Sebastián O; Mazzolai L; Krumholz HM; Monreal M;
    JAMA Cardiol; 2022 Aug; 7(8):857-865. PubMed ID: 35830171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.
    Frank B; Ariza L; Lamparter H; Grossmann V; Prochaska JH; Ullmann A; Kindler F; Weisser G; Walter U; Lackner KJ; Espinola-Klein C; Münzel T; Konstantinides SV; Wild PS;
    BMJ Open; 2015 Jul; 5(7):e008157. PubMed ID: 26133379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-related differences in D-dimer levels for venous thromboembolism screening.
    Reagh JJ; Zheng H; Stolz U; Parry BA; Chang AM; House SL; Giordano NJ; Cohen J; Singer AJ; Francis S; Prochaska JH; Zeserson E; Wild PS; Limkakeng AT; Walters EL; LoVecchio F; Theodoro D; Hollander JE; Kabrhel C; Fermann GJ
    Acad Emerg Med; 2021 Aug; 28(8):873-881. PubMed ID: 33497508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study.
    Sloan M; Sheth N; Lee GC
    Clin Orthop Relat Res; 2019 Mar; 477(3):523-532. PubMed ID: 30624321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboembolic outcomes are decreased with the use of a standardized venous thromboembolism risk assessment and prophylaxis protocol for patients undergoing superficial venous procedures.
    Braet DJ; Loi K; Stabler C; Vemuri C; Coleman DM; Obi AT; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2023 Sep; 11(5):928-937.e1. PubMed ID: 37127256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for presence and severity of pulmonary embolism in patients with deep venous thrombosis.
    Huynh N; Fares WH; Brownson K; Brahmandam A; Lee AI; Dardik A; Sarac T; Ochoa Chaar CI
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):7-12. PubMed ID: 29074107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
    Thromb Res; 2019 May; 177():1-9. PubMed ID: 30825719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).
    Huang W; Goldberg RJ; Cohen AT; Anderson FA; Kiefe CI; Gore JM; Spencer FA
    Thromb Res; 2015 Jun; 135(6):1100-6. PubMed ID: 25921936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased incidence of venous thromboembolism associated with inferior vena cava filter placement in patients diagnosed with isolated calf deep vein thrombosis after intracranial hemorrhage or intracranial operation.
    Juan MCY; Patel P; Zerona N; Christie A; Fendrikova Mahlay N; McLennan G; Tefera L
    J Thromb Thrombolysis; 2023 Feb; 55(2):297-303. PubMed ID: 36525155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based study.
    Brunson A; Ho G; White R; Wun T
    Thromb Res; 2017 May; 153():57-64. PubMed ID: 28334639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population-Based Historical Cohort Study of Middle-Aged and Older Individuals.
    Brink A; Elf J; Svensson PJ; Engström G; Melander O; Zöller B
    J Am Heart Assoc; 2023 Mar; 12(5):e027502. PubMed ID: 36847045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentasaccharides for the prevention of venous thromboembolism.
    Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic anticoagulants for non-hospitalised people with COVID-19.
    Santos BC; Flumignan RL; Civile VT; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD015102. PubMed ID: 37591523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
    Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
    J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-hospital outcomes of catheter-directed thrombolysis versus anticoagulation in cancer patients with proximal deep venous thrombosis.
    Brailovsky Y; Yeung HM; Lakhter V; Zack CJ; Zhao H; Bashir R
    J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):538-544.e3. PubMed ID: 31843480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of provoked deep venous thrombosis in a tertiary care center.
    Brownson KE; Brahmandam A; Huynh N; Reynolds J; Fares WH; Lee AI; Dardik A; Ochoa Chaar CI
    J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):477-484. PubMed ID: 28623981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis and systematic review of percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis.
    Wang W; Sun R; Chen Y; Liu C
    J Vasc Surg Venous Lymphat Disord; 2018 Nov; 6(6):788-800. PubMed ID: 30336908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.